Know Cancer

or
forgot password

Scripps Tumorgraft Study


N/A
21 Years
N/A
Open (Enrolling)
Both
Solid Tumor Malignancy or Hematologic Malignancy

Thank you

Trial Information

Scripps Tumorgraft Study


Inclusion Criteria:



- Age 21 or over

- diagnosis of a solid tumor malignancy, either resectable or metastatic or a
hematologic malignancy

- cognitively and emotionally able to give informed consent

Exclusion Criteria:

- Under age 21

- Not cognitively or emotionally able to give informed consent

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

Facilitate the development of individualized tumorgraft models for many different types of cancer.

Outcome Time Frame:

3 years

Safety Issue:

No

Principal Investigator

Laura Goetz, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Director, Applied Genetic Epidemiology

Authority:

United States: Institutional Review Board

Study ID:

12-6011

NCT ID:

NCT01726699

Start Date:

November 2012

Completion Date:

Related Keywords:

  • Solid Tumor Malignancy or Hematologic Malignancy
  • Neoplasms
  • Hematologic Neoplasms

Name

Location

Scripps Translational Science InstituteLa Jolla, California  92037